MARLOW, England, February 8 /PRNewswire/ --
- UK Launch of new and Gentle Dermal Filler Which Promises to Help Patients Feel the Difference and Provide Long-Lasting Results
Allergan, the makers of BOTOX(R) / VISTABEL(R) (botulinum toxin type A), today announced the UK launch of Juvéderm(R) ULTRA, a new range of dermal filler gel range for the treatment of facial wrinkles and folds. Juvéderm(R) ULTRA contains an anaesthetic, meaning people have a gentle injection experience. According to preliminary results from a study of 60 women released at the International Master Course on Aging Skin (IMCAS), 81% of people who received Juvederm(R) ULTRA felt only slight or no discomfort at all.(1)
Juvéderm(R) ULTRA is a 'hyaluronic acid' range of dermal fillers. Hyaluronic acid is a naturally occurring substance in the body which hydrates the skin and adds volume. As we age we naturally lose hyaluronic acid from the skin, a process which leads to the development of wrinkles and deep facial lines. Juvéderm(R) ULTRA works to replenish the skin's natural fullness and vitality and gives a smooth, long-lasting and natural look.
"For the majority of people seeking treatments such as Juvederm(R) ULTRA, it's about looking the best they possibly can. The main feedback that I hear from people who have tried Juvederm(R) ULTRA is that the results are natural, instant and without the discomfort often associated with other dermal filler products. The whole injection experience is a lot more comfortable and they are delighted with the results. My patients leave feeling rejuvenated and also knowing that the effects will last for a considerable period of time," said Dr Hilary Allan, Cosmetic Dermatologist at Woodford Medical Aesthetics in London.
People increasingly understand the value of looking good and the impact this has on how they feel and how people perceive them. A recent global beauty survey revealed that 8 out of 10 women across Europe and the United States want to look natural, which means wanting to look good for their age and as natural as possible to reflect their personality, expressions and emotional well-being, as opposed to just looking younger.(2)
Sharman Mcallister, 56-year-old software Company Director from Maidenhead: "I was always very self conscious of the creases that ran from the sides of my nose down to my mouth and felt they dragged my face down. I was happy to look into aesthetic treatment options but the idea of an injection did worry me. When my physician recommended I try Juvéderm(R) ULTRA, as it promised to be a more gentle experience, I jumped at the chance. I hardly felt a thing during the treatment and the results were immediate and fantastic. The great thing is I look better, but not different - I can actually look at myself in the mirror quite happily now."
Juvéderm(R) ULTRA is the latest offering from Allergan, the makers of VISTABEL(R), and forms part of the company's total facial offering of medical aesthetic treatments.
Juvéderm(R) ULTRA is injected into the skin using a fine needle. Uniquely, Juvederm(R) ULTRA contains anaesthetic which means that the process is gentle for the patient. The gel temporarily fills and augments the treatment area, adding volume and leaving the appearance of smoother surface and natural look. Juvéderm(R) ULTRA can be used for deep facial wrinkles and folds commonly known as the 'parenthesis lines' around the mouth and lower face area.
Allergan recommends that consumers considering treatment with Juvéderm(R) ULTRA only see an appropriately qualified and trained healthcare professional.
Notes to Editor
About the Juvéderm(R) ULTRA range
There are three different formulations for Juvéderm(R) ULTRA available including:
- Juvéderm(R) ULTRA 2, a highly cross-linked formulation for the subtle correction of facial lines
- Juvéderm(R) ULTRA 3, a highly cross-linked formulation for more versatility in contouring and volumising facial lines and nasolabial folds
- Juvéderm(R) ULTRA 4, a more highly cross-linked robust formulation for volumising and correction of deeper folds and wrinkles, including the cheeks and chin
Juvéderm(R) ULTRA is generally well tolerated, with most commonly reported side effects including temporary injection site redness, swelling, pain/tenderness, firmness, swelling, lumps/bumps, and bruising. Juvéderm(R) ULTRA is contraindicated for patients with severe allergies manifested by a history of anaphylaxis or history or presence of multiple severe allergies. Juvéderm(R) ULTRA also contains trace amounts of gram positive bacterial proteins and is contraindicated for patients with a history of allergies to such material.
With approx. 60 years of experience providing high-quality, science-based products, Allergan, with headquarters in Irvine, California, discovers, develops and commercialises products in the ophthalmology, neurosciences, medical dermatology, medical aesthetics, obesity intervention, urologics and other specialty markets that deliver value to its customers, satisfy unmet medical needs, and improve patients' lives. In addition to its discovery-to-development research programs, Allergan has global marketing and sales capabilities, with a presence in more than 100 countries. The company employs approximately 7,000 people worldwide and operates world-class research and development (R&D) facilities and several state-of-the-art manufacturing plants.
(1) Comparison of Injection Comfort and Ease with Juvéderm Ultra 3 and Surgiderm 30 XP. Phillip Levy, Hervé Raspaldo, Koenrad De Boulle. Accepted as a poster for IMCAS Jan 9-12, 2008, Paris
(2) Aesthetic Anthropology: Beauty Across Cultures, conducted on behalf of Allergan by Research International, July 2006
Media contacts: For further information please contact Janet Kettels from Allergan on +44(0)1628-494-4421 / +44(0)7738-5064-76 or firstname.lastname@example.org. Or, Chandler Chicco Agency: Julia Cross email@example.com / +44(0)207-632-1811, Lucy Hawkins firstname.lastname@example.org / +44(0)207-632-1981, Priya Lakhani-Quiling email@example.com / +44(0)207-6321809